T-group (topology)
3207.1.1 PmoA
Ligands and drugs
79
Member domains
51
with ligand contacts (≤ 4 Å)
64.6% of members
49
with DrugDomain annotations
62.0% of members
31
with a DrugBank compound
39.2% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 3207.1.1 belongs to X-group 3207 PmoA, which has 4 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02777 | PLC | Diundecyl Phosphatidyl Choline | 30 |
| DB03226 | ETF | Trifluoroethanol | 6 |
| DB04664 | CM5 | Cyclohexyl-pentyl-maltoside | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| D10 | DECANE | 36 |
| HXG | 1,2-dihexanoyl-sn-glycero-3-phosphocholine | 33 |
| P1O | 1,2-DIDECANOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 30 |
| PLC | DIUNDECYL PHOSPHATIDYL CHOLINE | 30 |
| ZNmetal | ZINC ION | 6 |
| 6ER | (S)-2,3-bis(hexanoyloxy)propyl(2-(trimethylammonio)ethyl)phosphate | 3 |
| CUmetal | COPPER (II) ION | 3 |
| CU1metal | COPPER (I) ION | 3 |
| D12 | DODECANE | 3 |
| ETF | TRIFLUOROETHANOL | 3 |
| WIY | 4,4,4-trifluorobutan-1-ol | 3 |
| 6PL | (4S,7R)-4-HYDROXY-N,N,N-TRIMETHYL-9-OXO-7-[(PALMITOYLOXY)METHYL]-3,5,8-TRIOXA-4-PHOSPHAHEXACOSAN-1-AMINIUM 4-OXIDE | 1 |
| CM5 | 5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE | 1 |
| PGT | (1S)-2-{[{[(2R)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE | 1 |